Weight Loss, Health & Longevity Benefits of GLP 1 Dr. J.E. Williams Key Findings: Duration Reduction: The study found that GLP 1 therapy significantly shortens the duration of BoNT A effects: In chronic migraine treatment, the mean duration dropped from 14.0 weeks to between 11.8 Glucagon Like Peptide 1 Receptor Agonists and Dual Glucose Dependent Insulinotropic Polypeptide Glucagon Like Peptide 1 Receptor Agonists in the Treatment of Obesity Metabolic Syndrome, Prediabetes Diabetes and Non Alcoholic Fatty Liver DiseaseCurrent Beyond Weight Loss: ED Implications of the GLP 1 Era EMOttawa Blog Frontiers Mechanisms of action and therapeutic applications of GLP 1 and dual GIP GLP 1 receptor agonists